PERSPECTIVE: Telithromycin - Acute Exacerbation of Chronic Bronchitis

PHASE4CompletedINTERVENTIONAL
Enrollment

5,660

Participants

Timeline

Start Date

January 31, 2004

Primary Completion Date

May 31, 2006

Study Completion Date

May 31, 2006

Conditions
Chronic Bronchitis
Interventions
DRUG

telithromycin

Trial Locations (8)

Unknown

Sanofi-Aventis, Bridgewater

Sanofi-Aventis, Brussels

Sanofi-Aventis, Paris

Sanofi-Aventis, Budapest

Sanofi-Aventis, Casablanca

Sanofi-Aventis, Barcelona

Sanofi-Aventis, Mégrine

Sanofi-Aventis, Istanbul

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Sanofi

INDUSTRY

NCT00132938 - PERSPECTIVE: Telithromycin - Acute Exacerbation of Chronic Bronchitis | Biotech Hunter | Biotech Hunter